Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Grapevine: The Complete Guide for Women, Families, and Survivors
At Attorney911, we recognize that many women in Grapevine chose breast reconstruction or augmentation as a path toward healing, confidence, or reclaiming their bodies after a difficult diagnosis. Whether you underwent a post-mastectomy reconstruction at a major surgical center in the Dallas-Fort Worth metroplex or chose a cosmetic mastopexy in the Southlake and Grapevine corridor, you trusted the medical devices implanted in your body were safe. For many women in Tarrant County, that trust has been shattered by complications involving surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds.
If you are experiencing persistent redness, swelling, localized pain, or a diagnosis of a rare lymphoma like BIA-ALCL, you are likely searching for answers that your surgical team may not have provided. We have built this resource to serve as the definitive educational guide for Grapevine residents—a place where clinical science meets legal reality. Our managing partner, Ralph Manginello, has spent twenty-seven years holding powerful institutions accountable, and our team, including associate attorney Lupe Peña, understands the nuances of medical device litigation. We are here to ensure that women in Grapevine and throughout the Northern District of Texas have the technical and legal depth required to stand against multi-billion-dollar manufacturers like Becton Dickinson, Allergan, and Integra LifeSciences.
Understanding the Devices: Mesh, ADM, and Scaffolds in Grapevine Surgical Suites
In Grapevine operating rooms, surgeons often use biological or synthetic materials to provide support for an implant, a technique frequently referred to as the “internal bra.” It is essential to distinguish between these categories to understand your potential legal claim:
- Acellular Dermal Matrix (ADM): Products like AlloDerm, Strattice, FlexHD, and AlloMax are biologic grafts derived from human or animal skin. The cells are removed, leaving a protein scaffold.
- Bioabsorbable Scaffolds: Synthetic products like GalaFLEX or Phasix are made of poly-4-hydroxybutyrate (P4HB). These are designed to provide temporary support and then resorb into the body through hydrolysis.
- Synthetic Surgical Mesh: Often polypropylene-based, these are permanent meshes sometimes used off-label in breast surgery to reinforce the lower pole of the breast.
The critical issue that women in Grapevine must understand is that many of these products were cleared through the FDA’s 510(k) “substantial equivalence” pathway. Under 21 USC §360c and 21 CFR Part 807, a device can be cleared if it is similar to an existing “predicate” device. This is a comparative shortcut, not an evaluative approval of safety. In fact, many scaffolds were cleared based on their similarity to surgical sutures—not on their performance in sensitive breast tissue. We find this “predicate creep” to be at the heart of many failures we investigate for Grapevine families.
The Complication Spectrum: What Grapevine Patients Need to Know
For a woman in Grapevine, a complication isn’t just a medical data point; it is a disruptive event that can lead to multiple revision surgeries. At Attorney911, we evaluate cases involving a wide range of harms documented in clinical literature:
BIA-ALCL and BIA-SCC: The Oncological Risks
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinct T-cell lymphoma, recognized by the World Health Organization since 2016. In many Grapevine cases, it presents as a late-onset seroma (fluid collection) occurring 7 to 10 years post-implantation. Pathologically, it is confirmed by CD30-positive and ALK-negative findings. Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC) is an even rarer epithelial tumor identified in the implant capsule. The FDA issued safety communications regarding BIA-SCC in September 2022 and March 2023, warning that this cancer can be found in the scar tissue surrounding even smooth implants.
Red Breast Syndrome and Endotoxin Science
Acellular dermal matrix products like FlexHD and AlloMax—both specifically named in the FDA’s March 31, 2021, safety communication—have been linked to Red Breast Syndrome (RBS). This is a non-infectious, sterile inflammation where the breast skin appears bright red. Research, including findings by Nguyen et al. (2019), points to endotoxins (lipopolysaccharides) retained on the matrix even after terminal sterilization. Because these endotoxins are not inactivated by irradiation, they trigger an aggressive inflammatory response once the ADM is inside a Grapevine patient’s body.
Mechanical and Bioabsorbable Failures
Scaffolds like GalaFLEX are marketed to resorb within 18 to 24 months. However, Manufacturer and User Facility Device Experience (MAUDE) reports show instances where the scaffold does not dissolve as promised, leaving sharp, palpable edges or causing chronic pain and “rippling” years after the surgery. Conversely, some scaffolds degrade too quickly, leading to “bottoming out” or loss of support before the patient’s own tissue has matured.
If you are a resident of Grapevine experiencing any of these symptoms, we encourage you to contact us at 1-888-ATTY-911 for a confidential case evaluation. Ralph Manginello and our firm work on a contingency basis—meaning we only get paid if we recover compensation for you.
The Regulatory Failure: The FDA’s 2023 Warning to Grapevine Healthcare Providers
A pivotal moment for legal claims in Grapevine occurred on November 9, 2023. The FDA issued a formal letter to healthcare providers regarding “Labeling Updates for BD Mesh Products.” In that document, the FDA stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
The letter explicitly named GalaFLEX and Phasix products. This admission by the federal regulator is significant for Grapevine residents because it highlights that these devices were used “off-label.” While surgeons are permitted to use devices off-label, manufacturers are prohibited from promoting them for unapproved uses. When a company like Becton Dickinson (BD) markets a product to Grapevine-area surgeons specifically for an “internal bra” technique that isn’t FDA-cleared, they may be liable for the resulting injuries.
Why Your Attorney’s Depth Matters in Tarrant County
Medical device litigation is significantly more complex than standard personal injury. In the Northern District of Texas, your legal team must overcome the hurdle of federal preemption. Under Riegel v. Medtronic (552 U.S. 312, 2008), state-law claims against devices that went through the rigorous Premarket Approval (PMA) process are often preempted. However, because most ADMs and scaffolds in the GalaFLEX or Phasix family used the 510(k) pathway, the precedent in Medtronic v. Lohr (518 U.S. 470, 1996) typically applies, meaning your right to sue under state law remains intact.
Generalist firms in Grapevine may not understand the “parallel-claim” exception or the nuances of the Buckman Co. v. Plaintiffs’ Legal Committee (531 U.S. 341, 2001) ruling regarding fraud-on-the-FDA. Ralph Manginello and Lupe Peña are well-versed in these doctrinal battlegrounds. We utilize our deep knowledge of 21 CFR Part 803 (Medical Device Reporting) to identify when a manufacturer failed to warn Grapevine doctors about known risks.
High-Profile Litigation Capability: The Attorney911 Advantage
When choosing counsel for a case against a global manufacturer, you need a firm with a record of handling complex, multi-defendant institutional liability. At Attorney911, we are currently lead counsel in Bermudez v. Pi Kappa Phi, a high-profile case filed in November 2025 seeking $10,000,000 in damages against thirteen defendants. This experience in managing litigation involving massive organizations—and our success in forcing institutional change—is the same caliber of aggressive representation we bring to defective breast mesh cases in Grapevine.
Lupe Peña, a third-generation Texan, also provides a critical advantage for Grapevine’s Spanish-speaking community. Lupe conducts full consultations in fluent Spanish, ensuring that no technical detail is lost in translation. Hablamos español to ensure every woman in Grapevine has access to elite legal counsel.
Frequently Asked Questions for Grapevine Residents
1. Is surgical mesh approved for breast surgery?
No. The FDA specifically stated in November 2023 that no surgical mesh products, including scaffolds like GalaFLEX or ADMs like FlexHD, have been cleared or approved for use in breast surgery. Their use in Grapevine clinics is considered “off-label.”
2. Can I sue if my GalaFLEX mesh was bioabsorbable?
Yes. Many Grapevine patients have experienced injuries from bioabsorbable scaffolds, including chronic pain, inflammation, and failure to resorb. The fact that the material is intended to dissolve does not exempt the manufacturer from liability if the device was defectively designed or marketed.
3. What is the statute of limitations in Grapevine?
In Texas, the general statute of limitations for personal injury is two years from the date of injury. However, the “discovery rule” may apply. In Grapevine cases, we often argue that the clock did not start until the patient discovered—or reasonably should have discovered—the link between their injury and the defective device, often triggered by an FDA safety communication or a revision surgery.
4. Who do I sue for my mesh injury?
The primary target in these lawsuits is typically the manufacturer (such as Becton Dickinson, Allergan, or MTF Biologics) for failure to warn and design defects. In some Grapevine cases, there may also be a medical malpractice component if the surgeon failed to obtain informed consent regarding the off-label status of the mesh.
5. How do I find out what brand of mesh was used in my surgery?
We help Grapevine clients request their full operative reports and “implant stickers” from the hospital. Hospitals like Baylor Scott & White Grapevine or regional centers in Fort Worth are required to maintain records of the Unique Device Identifier (UDI) and lot numbers for any implanted product.
6. What if I had my reconstruction years ago in Grapevine?
Even if your surgery was years ago, if you have recently developed a late seroma, capsular contracture, or been diagnosed with BIA-ALCL, you may still have a case. Texas has a 15-year statute of repose for product liability, but exceptions exist, especially in cases of latent injuries like cancer.
7. What is red breast syndrome?
It is a sterile inflammatory reaction to certain acellular dermal matrix products. Many women in the Grapevine area have undergone revision surgery because of this persistent redness that does not respond to antibiotics, as it is caused by endotoxins on the graft, not an active bacterial infection.
8. Who is Dr. Hooman Noorchashm?
Dr. Noorchashm is a prominent whistleblower and surgeon who was a former Medical Director at BD/Bard. He raised significant concerns about the safety of products like GalaFLEX and Phasix in breast tissue and alleges that manufacturers withheld cancer recurrence data from the FDA.
9. Can I file a claim if I have “breast implant illness” (BII)?
While BII is not currently a stand-alone FDA diagnosis like BIA-ALCL, many women in Grapevine are successfully bringing claims when their systemic symptoms (fatigue, joint pain, brain fog) are linked to defective textured implants or inflammatory mesh scaffolds.
10. Does a lawsuit cost me anything upfront?
No. At Attorney911, our Grapevine clients never pay a dime unless we win. We advance all costs for expert witnesses, medical record retrieval, and litigation.
Steps for Grapevine Patients to Take Today
If you suspect your breast reconstruction or augmentation in Grapevine is failing, we recommend taking the following steps immediately to preserve your rights:
- Request Your Records: Secure your operative report and implant log. Look for brand names like GalaFLEX, Phasix, AlloDerm, Strattice, or FlexHD.
- Documentation: Take photographs of any visible symptoms, such as redness, asymmetrical swelling, or skin changes. Keeping a journal of your pain levels is also valuable evidence for a Grapevine jury.
- Medical Evaluation: Visit your surgeon or a specialist for an ultrasound or MRI. If fluid is discovered, ensure it is tested for CD30-positive markers to rule out BIA-ALCL.
- Preserve the Evidence: If you undergo revision surgery in Grapevine, instruct your surgeon to “explant” the mesh or scaffold and have it preserved as evidence rather than being destroyed as medical waste.
- Consult Counsel: Contact the experienced litigators at Attorney911 once you feel ready.
Protecting the Women of Grapevine and Tarrant County
Ralph Manginello’s twenty-seven years of practice and the firm’s Avvo “Excellent” 8.2 rating reflect a commitment to elite advocacy for the injured. We hold Martindale-Hubbell Preeminent honors and have earned hundreds of five-star reviews on Birdeye and Google. We aren’t just local lawyers; we are a federal-court-admitted litigation team capable of taking on the world’s largest medical device companies.
From our principal office in Houston, we serve the entire state of Texas, including our clients in Grapevine, Keller, and Colleyville. We understand the Grapevine community—from the historic downtown to the growing medical infrastructure surrounding DFW. We believe that no woman in Grapevine should have to bear the financial and emotional burden of a manufacturer’s quest for market share via off-label promotion.
When you are ready to talk about what happened to you at your Grapevine surgical appointment, call us at 1-888-ATTY-911 (1-888-288-9911). Our associate, Lupe Peña, is ready to assist our Spanish-speaking neighbors, and Ralph Manginello is ready to put his nearly three decades of experience to work for your family. There is no cost for a consultation, no obligation, and no fee unless we win. Your health is your life; let us protect your rights.
Resources for Grapevine Families
We recommend the following independent resources for women in Grapevine navigating a potential device injury:
- American Cancer Society: 1-800-227-2345 (National support).
- Susan G. Komen Breast Care Helpline: 1-877-465-6636 (Support for Grapevine survivors).
- FDA MedWatch: Reports of injuries in Grapevine can be filed directly with the FDA to help track device failures.
- PROFILE Registry: The PSF.org/PROFILE (The primary registry for BIA-ALCL).
Our goal at Attorney911 is to give the women of Grapevine the agency and comprehension they need to handle the complications of defective breast mesh. We are with you every step of the way. Call us now.
